Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 92006781 | 9200678 | 1 | I | 200702 | 20130322 | 20130331 | 20130331 | EXP | GB-TEVA-394407ISR | TEVA | 50.00 | YR | F | Y | 54.00000 | KG | 20130331 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 92006781 | 9200678 | 1 | PS | PREDNISOLONE | 1 | 20MG INITIALLY. FROM APRIL 12 - NOVEMBER 12 I STOPPED STEROIDS. | U | 89081 | 20 | MG | |||||||||
| 92006781 | 9200678 | 2 | SS | PREDNISOLONE | 1 | U | 89081 | 5 | MG | QD | |||||||||
| 92006781 | 9200678 | 3 | SS | HYDROXYCHLOROQUINE | 1 | BRIEF PERIOD OF STOPPING FEB 12 - AUG 12. | U | 0 | 200 | MG | QD | ||||||||
| 92006781 | 9200678 | 4 | SS | HYDROXYCHLOROQUINE | 1 | BRIEF PERIOD OF STOPPING FEB 12 - AUG 12. | U | 0 | 200 | MG | QD | ||||||||
| 92006781 | 9200678 | 5 | C | VOLTAROL | 1 | ORAL | D | 0 | 50 | MG | |||||||||
| 92006781 | 9200678 | 6 | C | CO-CODAMOL | 1 | 30/500MG | D | 0 | |||||||||||
| 92006781 | 9200678 | 7 | C | FERROUS FUMARATE | 1 | D | 0 | 200 | MG | BID | |||||||||
| 92006781 | 9200678 | 8 | C | OPTICROM | 1 | OTHER | 2 DROPS EACH EYE BD | D | 0 | 2 | DF | BID | |||||||
| 92006781 | 9200678 | 9 | C | BECONASE | 1 | NASAL | 2 PUFFS EACH NOSTRIL BD | D | 0 | 2 | DF | BID | |||||||
| 92006781 | 9200678 | 10 | C | AMITRIPTYLINE | 1 | 1 NOCTE | D | 0 | 10 | MG | QD | ||||||||
| 92006781 | 9200678 | 11 | C | OSTEOCARE | 1 | ORAL | D | 0 | 2 | DF | BID | ||||||||
| 92006781 | 9200678 | 12 | C | EVENING PRIMROSE OIL | 1 | D | 0 | 500 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 92006781 | 9200678 | 1 | Systemic lupus erythematosus |
| 92006781 | 9200678 | 2 | Systemic lupus erythematosus |
| 92006781 | 9200678 | 3 | Connective tissue disorder |
| 92006781 | 9200678 | 4 | Connective tissue disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 92006781 | 9200678 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 92006781 | 9200678 | Erythema | |
| 92006781 | 9200678 | Facial pain | |
| 92006781 | 9200678 | Inflammation | |
| 92006781 | 9200678 | Pain | |
| 92006781 | 9200678 | Paraesthesia | |
| 92006781 | 9200678 | Photosensitivity reaction | |
| 92006781 | 9200678 | Rash |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 92006781 | 9200678 | 1 | 200712 | 0 | ||
| 92006781 | 9200678 | 2 | 201212 | 0 | ||
| 92006781 | 9200678 | 3 | 200701 | 201202 | 0 | |
| 92006781 | 9200678 | 4 | 201209 | 0 |